Seizures Flashcards

(49 cards)

1
Q

Definitions

A

Seizures: excessive electrical discharge of cortical neurons resulting in disruption of brain fxn and change in behavior-> 10% of gen pop will have atleast one seizure in their lifetime

Epilepsy: two or more unprovoked seizures-> 125,000 new cases per yr-> affect ~2 mill pple in US

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mechanisms of seizures

A
  1. Abnormal firing of neurons-> increased excitability, ion channels (Na, Ca)
  2. Increased excitatory amino acids-> Glutamate, aspartate
  3. Decreased inhibitory process-> GABA
  4. Interference w/ metabolic processes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Classification of seizures

A
  1. Focal seizures: Old classification= partial
  2. Generalized seizures: involve both hemispheres of the brain from the beginning of seizure
  3. Unknown onset: newer term from International League Against Epilepsy (ILAE)-> includes: tonic-clonic, atonic, and epileptic spasms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Exitatory vs Inhibitory factors

A

Excitatory:
-Glutamatergic neurons
-Mod of the release of excitatory nt glutamate
-Na channels
-AMPA receptors and Kainate receptors (coupled to K+ and Ca 2+ channels)

Inhibitory:
GABAergic neurons
GABAa receptors
GABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Focal vs Generalized seizures - summary

A

good summary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA targets of antiseizure drugs

A
  1. Voltage-gated ion channels
  2. Inhibition of GABA
  3. Synaptic release components
  4. Ionotropic glutamate receptors
  5. Disease specific targets
  6. mixed/unknown
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anticonvulsant MOA

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

“spectrum” of antiseizure drug activity

A

Narrow spectrum: designed for specific seizure types-> approp if seizures occur in one specific part of the brain on a regular basis

Broad spectrum: designed to prevent seizures in more than one part of the brain-> tx more than one seizure subtype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Tx of epilepsy- principles

A

must be individualized
establish the diagnosis (type of seizure)
select apprp drug for seizure type-> efficacy and SE
Establish therapeutic goals
Strive for monotherapy in seizure control
Anticipate age-related changes in drug response
-pharmacokinetic differences
-pharmacodynamic differences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

tx of epilepsy choosing AED

A

Antiepileptic drug:
Efficacy
safety
cost (generic formulations of older drugs)
drug interactions
dosing frequency
dosage form
-ease of swallowing
-liquid forms
-mixing w/ food

HIGH MED INTERACTIONS + DIZZY+ GI ISSUES + DROWSY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

tx of epilepsy monitoring

A

Monitoring: important for management of most AED
Start at initiation and in early stages of tx
DRUG LEVELS ARE A THERAPEUTIC GUIDELINE-> NOT A HARD AND FAST RULE-> may see response @ concentrations “below” or “above” the therapeutic range-> always combine w/ clinical assessment-> expensive and may not be necessary in all pts

Blood
LFTs
CBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Problems w/ some traditional 1st gen AEDs

A

poor water solubility
extensive protein-binding
autoinduction of cytochrome p450 system (carbamazepine)
many drug-drug interactions (all)
Phenobarbital- schedule lV drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

AE of antiseizure meds

A

GI (N/V)
Sedation
Ataxia
Rash
Hyponatremia
weight gain or loss
teratogenicity
osteoporosis

summary= DIZZINESS, DROWSINESS, GI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pharmacokinetics of AEDs

A

gray= 1st gen higher protein binding
blue= 2nd gen mod
green= 3rd gen Low protein binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Phenobarbital (PB)

A

brand name: Luminal (1912)
low cost and effective
barbiturate w/ sedative, hypnotic, anticonvulsant properties

Indications:
focal, generalized tonic-clonic seizures, status epilepticus

MOA: enhances the inhibitory actions of GABA neurons

SE: CNS (impaired cognition, sedation, confusion, memory problems, ataxia, hyperactivity in children, CNS depression), blood dyscrasias, osteomalacia, stevens johnson syndrome (SJS), can be abused

Drug interactions: alot of other meds effecting dosing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Primidone (Mysoline)

A

Indications: tonic-clonic seizures, focal, psychomotor (temporal lobe) seizures

MOA: Initially blocks Na channels but is converted to phenobarbital-> GABA EFFECTS

SE and AE: very sedating like phenobarbital

Monitor: Blood counts and LFTs

Special notes: supplement w/ folic acid
not used much

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Benzodiazepines

A

used for acute/short term use: Generalized anxiety disorder, seizure cessation, alcohol withdrawal, muscle spasms, insomnia

MOA: increase frequency of GABA receptor opening- development of tolerance limits THEIR USE IN CHRONIC TX of EPILEPSY

Lorazepam, diazepam, midazolam= RESCUE MEDICATIONS FOR ACUTE REPETITIVE SEIZURES OR STATUS EPILEPTICUS-> USUALLY REQUIRES TAPERING TO DC IF USED FOR >4 WEEKS

Warnings: sedation, tolerance, hypnosis/amnesia, respiratory depression
PREGNANCY CATEGORY D= AVOID
LIVER DISEASE = AVOID

drug interactions: sedatives and opioids

ANTIDOTE (BENZODIAZEPINE REVERSAL AGENT)-> FLUMAZENIL= can cause withdrawal and seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Clonazepam (Klonopin)

A

Indications: Lennox-Gastaut syndrome, myoclonic seizures, refractory abscence seizures, infantile spasms

SE/AE: salivation, blood dyscrasias

Drug interactions: other seizure meds (may need dose adjustment), other sedatives/hypnotics

Monitoring: CBC, LFTS, renal fxn with long term therapy

MAY PRECIPITATE TONIC-CLONIC SEIZURES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Lennox-Gestaut syndrome

A

childhood epileptic encephalopathy= multiple seizure types= 10% of epilepsies presenting <5 yo
patho unknown= idiopathic or triggered by underlying disorder (meningitis, tuberous sclerosis, malformations)-> prognosis varies but generally poor, mental regression is common

1st line: Valproate = no optimal therapy highlighted though

specialized anticonvulsants tx:
1. Rufinamide (Banzel)- hepatic metabolism (complex interactions with other seizure meds)-> contra in pts w. FAMILIAL SHORT QT SYNDROME
2. Felbamate (Felbatol) 2nd line for partial/complex seizures-> lot of interactions-> contra in liver dz, blood dyscrasias
3. Clobazam (Onfi, Sympazan)= benzo-> adjunctive tx in pts greater than or equal to 2 yrs-> effect potentiated by drugs like omeprazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Phenytoin

A

Brand name: Dilantin
chem structure like barbiturates
indicated: generalized and focal seizures

Moa: block frequency, use, and voltage dependent neuronal Na channels-> limit repetitive firing of AP

Distribution: enters brain rapidly and redistributes-> highly protein bound (90%) rapidly and reversibly bound= AFFECTED BY: LOW ALBUMIN, RENAL FAILURE, AGE, OTHER DRUGS

Metabolism: ELMINATION CHANGES FROM 1ST ORDER (LINEAR) TO ZERO ORDER (NONLINEAR) IN THE THERAPEUTIC RANGE

increases in pregnancy-> DO NOT USE IN PREGNANCY (FETAL HYDANTOIN SYNDROME (CLEFT PALATE, CONGENITAL HEART DZ, INTELLECTUAL DISABILITY AND OTHERS))

BBW: administration of IV FORM-> DO NOT EXCEED 50 MG/MIN IN ADULTS OR 1TO 3 MG/KG/MIN-> RISK OF SEVERE HTN AND CARDIAC ARRHYTHMIAS

SE:
NYSTAGMUS
LETHARGY
COGNITIVE IMPAIRMENT
GINGIVAL HYPERPLASIA

AE: Low / med/high/ severe -> no numbers needed

21
Q

Fosphenytoin (Cerebryx)

A

water soluble prodrug of phenytoin (replaced phenyt for IV)
used in acute attacks status epilepticus or as seizure prophylaxis-> used as a loading dose when starting phenytoin

AE: Cerebellar symptoms (ataxia, vertigo, nystagmus, diplopia), pruritis, burning sensation

bbw like phenytoin

22
Q

Carbamazepine (CBZ)

A

Brand names: Tegretol, Carbatrol
MOA: primarily via inhibition of voltage gated NA channels
also used for bipolar disorder and trigeminal neuralgia

unique metabolism: Autoinduction (drug induces CYP450 and increases its own metabolism)

Drug interactions:
CBZ= enzyme inducer-> other drugs may induce or inhibit metab-> sedative

AE:
common: HYPONATREMIA, nvd, HA, dizzy, blurred vision
rare: STEVENS JOHNSON/TOXIC EPIDERMAL NECROLYSIS-> HLA-B 1502 OR HLA-A 3101 ASIAN POPULATIONS

Pt ed: DO NOT CRUSH OR CHEW-> “GHOST” OF SHELL IN STOOL W/ Tegretol XR
carbatrol can be opened and mixed w/ food
exposure to heat and humidity may harden tablets-> decreasing bioavailability

newer drug: Oxcarbazepine (Trileptal) se same but No autoinduction still high interactions

23
Q

Oxcarbazepine (Trileptal)

A

Derived from carbamazepine-> fewest drug ineractions-> less potent than carbamazepine

Indications: focal and generalized tonic-clonic seizures, neuropathic pain, bipolar disorder

MOA: Blocks Na+ channels

SE: sedation, HA, dizziness, rash, vertigo, ataxia, nausea, hyponatremia (more common w/ trileptal vs. carbamazepine)

AE: SJS/TEN

drug interactions: other AEDs and verapamil

improved SE profile over carbamazepine bc NOT AN ENZYME INDUCER BC DIFF SIDE CHAIN WHICH ALLOWS IT TO BE METABOLIZED AND ELIMINATED DIFFERENTLY

24
Q

Hyponatremia assoc w/ Oxcarbazepine and Carbamazepine

A

well described AE
PT MAY BE ASYMPTOMATIC-> may develop over the first few months of therapy
monitoring: BASELINE AND @ THERAPEUTIC LEVEL and IF DEVELOP SXS OF HYPONATREMIA WHILE ON CHRONIC THERAPY

RF: older age, higher serum level of oxcarbazepine/carb, on >1 drug for seizure, concurrent use of antihtn meds (diuretics mainly), history of hyponatremia w/ either drug

25
Valproic acid/ Valproate- know this one
Brand name: Depakote Indications: Generalized and Focal seizure= MOST EFFECTIVE ANTISEIZURE MEDICATIONS absence epilepsy, migraine prophylaxis, anxiety disorders, bipolar disorder Drug interactions: other seizure meds, aspirin MOA: blocks voltage dependent sodium channels, increase GABA CONC by blocking GABA transaminase, act against T-type calcium channels Divalproex= long acting formulation compromised of sodium valproate and valproic acid high protein binding-> high drug interactions AVOID IN PREGNANCY-> TERATOGENIC NEURAL TUBE DEFECTS MOST TERATOGENIC OF ALL ANTISEIZURE DRUGS AE: GI, TREMOR, WEIGHT GAIN, RASH SJS, ELEVATED LFT, HEPATOTOXICITY RARE, LIVER FAILURE CAN BE FATAL, hyperammonemia (VHE)-> valproate- related hyperammonemic encephalopathy If you VALue your liver, be careful when taking VALproic acid= acute hepatocellular injury
26
Problems w/ older
1st gen and 2nd gen AEDS
27
Gabapentin (Neurontin, Gralise)
structurally related to GABA does not bind to GABA A OR GABAB receptors and does not appear to affect degradation or uptake of GABA Moa: uncertain Indications: focal onset seizures, neuropathic pain, postherpetic neuralgia, off label: use includes restless legs syndrome and hiccups interactions: no major, sedatives AE: MC: dizzy, somnolence, fatigue, ataxia, weight gain, edema rare: rash, tremor, DIPLOPIA, DRESS (drug rxn w/ eosinophilia and systemic symptoms Caution: kidneys excrete drug unchanged= MUST REDUCE IN PTS W/ RENAL IMPAIRMENT
28
Gabapentinoid- Pregabalin (Lyrica)
chemically related to gabapentin indications: adjunctive therapy for focal seizures: -neuropathic pain including diabetic neuropathy and postherpetic neuralgia, fibromyalgia MOA: binds to a specific subunit of voltage gated Ca channels which modulates Ca influx-> inhibits neuronal excitability by inhibiting release of excitatory nt, serotonin, dopamine, substance P, and calcitonin SE/AE: Arrhythmias, Thrombocytopenia Metabolism-> Renally excreted-> relatively unchanged so dose adj required Drug interactions- none other than other seizure meds CONTROLLED SUBSTANCE DUE TO RISK OF ABUSE
29
Lamotrigine (Lamictal)
MOA: inhibition of Voltage sensitive Na channels-> decreases release of glutamate and aspartate Indications: adjunctive therapy for focal onset seizures-> primary generalized tonic clonic seizures-> Lennox Gastaut syndrome IMPROVES DEPRESSION IN PTS W/ EPILEPSY Interactions: PHenytoin, CBZ, VPA inhibits, hormone replacement therapy increases clearance and decreases blood levels WARNINGS: RASH INCLUDING DRESS AE: MC: N, dizzy, somnolence, blurred vision, insomnia RARE: STEVENS JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS TEN Caution: PTS W/ STRUCTURAL OR FUNCTIONAL HEART DISEASE, conduction system disease, congenital heart disease, ventricular arrhythmia, or multiple risk factors for coronary artery disease
30
Topiramate (Topamax)
Indications: focal (partial) onset seizures, primary generalized tonic clonic seizures, adj therapy for lennox gastaut syndrome, Migraine prophylaxis MOA: many AVOID IN PREGNANCY AE: Mc: WEIGHT LOSS, WORD FINDING DIFFICULTIES, KIDNEY STONES, METABOLIC ACIDOSIS, OLIGOHYDROSIS rare: glaucoma Interactions: lithium, antiseizure drugs, contraceptives, cns depressants
31
Levetiracetam (Keppra)
chemically unrelated to other AEDs Indications: focal and primary generalized tonic clonic seizures, status epilepticus, juvenile myoclonic epilepsy, seizure prophylaxis MOA: many drug interactions: CNS depressants SE: better SE than other anticonvulsnats -weakness, dizziness, ataxia, somolence
32
Ethosuximide (Zarontin)
for Absence seizures MOA: increases seizure threshold and suppresses paroxysmal "spike and wave" pattern in abscence seizures-> thought to inhibit T-type Ca2+ channels-> depresses nerve transmission in motor cortex SE: N, HA, dizziness, lethargy Drug interactions: other seizure meds and SSRIs cautions: COAGULATION DISORDERS, LUPUS, RENAL DZ, HISTORY OF SUICIDAL IDEATION PE: Administer w/ food or milk to minimize GI upset
33
Fenfluramine (Fintepla)
indicated for seizures assoc w/ Dravet syndrome (DS)-> infancy epilepsy MOA: uncertain AE: drowsiness, lethargy, reduced appetite, weight loss MUST DO BIANNUAL ECHO TO MONITOR FOR DEVELOPMENT OF VALVULOPATHY AND/OR PULMONARY HTN
34
Vigabatrin (Sabril)
indications: refractory focal seizures (adj) and infantile spasms (monotherapy) MOA: inhibits enzyme responsible for GABA catabolism (GABA transaminase) SE: drowsiness, fatigue, HA, dizziness-> HIGH RISK OF VISUAL FIELD LOSS high risk drug: part of REMS program = Risk Evaluation and Mitigation Strategies
35
Lacosamide (Vimpat)
MOA: sodium channel blocker CARDIAC WARNINGS-> not recommended w/: known conduction/rhythm abnormalities, AV blocks, afib, atrial flutter, concomitant drugs that increase PR interval prolongation, severe cardiac dz, myocardial ischemia, MI, heart failure indications: focal seizures, primary generalized tonic clonic seizures AE: common: blurred vision, dizziness, vertigo Rare: cardiac warnings and DRESS
36
Tigabine (Gabitril)
indications: Focal seizures MOA: GABA re-uptake inhibitor SE: dizzy, lack of energy, somnolence, nausea, nervousness drug interactions: pharmacokinetics affected by other AEDs
37
Status epilepticus
more than or equal to 2 seizures occur w/out full recovery of consciousness btwn episodes can be focal/generalized and convulsive or nonconvulsive life-threatening -> requires emergency intervention
38
Tx of status epilepticus
1. Fast acting benzodiazepine a. Lorazepam (Ativan) IV b. Midazolam (Versed) IM, intranasal, buccal c. Diazepam (Valium) IV or rectal 2. Slower acting antiseizure a. Phenytoin/fosphenytoin b. Divalproex c. Levetiracetam
39
Diazepam (Valium)
indications: acute active seizures muscle spasm/rigidity, alcohol withdrawal syndrome, alt status epilepticus, anxiety MOA: increases GABA activity SE: Sedation and habit forming Contrain: GLAUCOMA BBW: Benzo w/ opioids + abuse, misuse, addiction + dependence and w/drawal interactions: many AVOID ABRUPT CESSATION
40
Tx algorithm for Generalized convulsive status epilepticus- b familiar w/
1. Prehospital care: vitals + Diazepam or Midazolam-> go to hospital 2. initial hospital care: asses airway + catheter + IV fluids (thiamine, pyridoxine, glucose, naloxone, AB 3. Impending GSCE (0-30 min) = IV Lorazepam and repeat in 5 min 4. Established GSCE (30-60 min) 1st line: Phenytoin, Valproate, Levetiracetam 2nd line: Phenobarbital 3rd line: Lacosamide
41
DRESS
Drug Rxn w/ Eosinophilia and systemic symptoms rare-> life threatening cutaneous eruption, hematologic abnormalities, lymphadenopathy, and or internal organ involvement triggered by antiseizure medications + allopurinol, sulfonamides, minocycline, vancomycin HIGHLY SUSCEPTIBLE POPULATIONS: CARBAMAZEPINE-> EUROPEAN, JAPANESE, HAN CHINESE PHENYTOIN-> HAN CHINESE, THAI *drugs that cause DRESS: carbamazepine, phenytoin, lamotrigine, oxcarbazepine, phenobarbital
42
AED assoc w/ DRESS, SJS, TEN
carbamazepine, oxcarbazepine, lamotrigine, phenytoin, phenobarbital, primidone, zonisamide
43
Drug review- good summary slide
44
Concerns about AEDs in pediatric pts
1. Gabapentin-> weight gain and behavioral AE 2. Lamotrigine -> Skin rash, cns, slow titration 3. Topiramate-> CNS AE, weight loss, slow titration
45
concerns about AEDs in Elderly pts
Gabapentin (elimination low in renal fxn, edema, cns effects) Lamotrigine (cns effects, rash, slow dosage titration) Topiramate (elimination low in renal fxn, cns effects, weight loss, nephrolithiasis, slow dosage titration)
46
Discontinuation or Withdrawal of AED therapy
assess risk of recurrent seizure SHOULD B SEIZURE FREE FOR 2-5 YRS ON AEDS withdraw pt over an extended period of time complicated: single type of seizure, normal neurologic exam/normal IQ, EEG normalized w/ tx
47
Epilepsy in pregnancy
Pre pregnancy: AEDs may result in OCP failures During: potential teratogenicity, effect of seizures on fetus, higher risk pregnancy, change in AED pharmacokinetics Postpartum: change in pharmacokinetics-> passage through breast milk
48
Teratogenic risk profiles of antiseizure meds
least bad: lamotrigine and levetriacetam carbamazepine, oxcarbazepine, zonisamide phenytoin, phenobarbital, topiramate worst: Valproic acid
49
pt counseling information
compliance: noncompliance is a major cause of status epilepticus and failure to respond to AEDs improving compliance: cargiver reinforce compliance every time simplify dosage regimen to daily tailor dosage to pts schedule provide compliance enhancers help pt develop system to take meds and record AED dosing